IL176762A0 - Pharmaceutical compositions comprising growth hormone and a statin - Google Patents
Pharmaceutical compositions comprising growth hormone and a statinInfo
- Publication number
- IL176762A0 IL176762A0 IL176762A IL17676206A IL176762A0 IL 176762 A0 IL176762 A0 IL 176762A0 IL 176762 A IL176762 A IL 176762A IL 17676206 A IL17676206 A IL 17676206A IL 176762 A0 IL176762 A0 IL 176762A0
- Authority
- IL
- Israel
- Prior art keywords
- statin
- pharmaceutical compositions
- growth hormone
- hormone
- growth
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54020404P | 2004-01-29 | 2004-01-29 | |
| US54336604P | 2004-02-10 | 2004-02-10 | |
| PCT/EP2005/000758 WO2005074916A1 (en) | 2004-01-29 | 2005-01-26 | Methods and compositions for the treatment of lipodystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL176762A0 true IL176762A0 (en) | 2006-10-31 |
Family
ID=34841102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL176762A IL176762A0 (en) | 2004-01-29 | 2006-07-10 | Pharmaceutical compositions comprising growth hormone and a statin |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1722778A1 (ru) |
| JP (1) | JP2007519669A (ru) |
| KR (1) | KR20060127977A (ru) |
| AU (1) | AU2005210093A1 (ru) |
| BR (1) | BRPI0507302A (ru) |
| CA (1) | CA2552404A1 (ru) |
| EA (1) | EA200601392A1 (ru) |
| IL (1) | IL176762A0 (ru) |
| NO (1) | NO20063279L (ru) |
| WO (1) | WO2005074916A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2903312B1 (fr) | 2006-07-05 | 2008-09-26 | Univ Aix Marseille Ii | Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament |
| CN103372215B (zh) * | 2008-01-03 | 2016-03-09 | 艾克斯-马赛大学 | 抗hiv治疗期间使用的组合物和方法 |
| US20100267636A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechnologies Inc. | Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy |
| JP6712230B2 (ja) * | 2014-03-11 | 2020-06-17 | ノバルティス アーゲー | リポジストロフィーおよびインスリン産生の欠損またはインスリンシグナル伝達の欠損と関連する代謝性障害を処置する方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9803623D0 (sv) * | 1998-10-22 | 1998-10-22 | Sahltech Ab | New therapeutic application |
-
2005
- 2005-01-26 CA CA002552404A patent/CA2552404A1/en not_active Abandoned
- 2005-01-26 KR KR1020067016376A patent/KR20060127977A/ko not_active Application Discontinuation
- 2005-01-26 WO PCT/EP2005/000758 patent/WO2005074916A1/en active Application Filing
- 2005-01-26 JP JP2006550092A patent/JP2007519669A/ja active Pending
- 2005-01-26 AU AU2005210093A patent/AU2005210093A1/en not_active Abandoned
- 2005-01-26 BR BRPI0507302-2A patent/BRPI0507302A/pt not_active IP Right Cessation
- 2005-01-26 EP EP05707019A patent/EP1722778A1/en not_active Withdrawn
- 2005-01-26 EA EA200601392A patent/EA200601392A1/ru unknown
-
2006
- 2006-07-10 IL IL176762A patent/IL176762A0/en unknown
- 2006-07-14 NO NO20063279A patent/NO20063279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0507302A (pt) | 2007-06-26 |
| NO20063279L (no) | 2006-09-19 |
| JP2007519669A (ja) | 2007-07-19 |
| WO2005074916A1 (en) | 2005-08-18 |
| AU2005210093A1 (en) | 2005-08-18 |
| KR20060127977A (ko) | 2006-12-13 |
| EP1722778A1 (en) | 2006-11-22 |
| CA2552404A1 (en) | 2005-08-18 |
| EA200601392A1 (ru) | 2006-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0413730D0 (en) | A pharmaceutical composition and its use | |
| IL179795A0 (en) | A pharmaceutical composition and its use | |
| GB0403247D0 (en) | A pharmaceutical composition | |
| AU2003291103A8 (en) | Pharmaceutical composition | |
| IL177480A0 (en) | Pharmaceutical composition | |
| IL164547A0 (en) | Pharmaceutical composition | |
| IL183986A0 (en) | Pharmaceutical compounds and compositions | |
| IL178067A0 (en) | Pharmaceutical dosage forms and compositions | |
| IL165878A0 (en) | Pharmaceutical composition | |
| GB2391809B (en) | Pharmaceutical composition comprising honey | |
| ZA200701527B (en) | Composition comprising statin | |
| EP1496913A4 (en) | NEUROPROTECTIVE PHARMACEUTICAL SPIROSTENOL COMPOSITIONS | |
| EP1765373A4 (en) | OZONIZED PHARMACEUTICAL COMPOSITION AND METHOD THEREOF | |
| PL1802329T3 (pl) | Formulacja farmaceutyczna zawierająca krystaliczną insulinę oraz rozpuszczoną insulinę | |
| ZA200704926B (en) | Modified human growth hormone | |
| IL176762A0 (en) | Pharmaceutical compositions comprising growth hormone and a statin | |
| HU0401177D0 (en) | Pharmaceutical composition | |
| GB2411355B (en) | Pharmaceutical composition | |
| GB0400452D0 (en) | A pharmaceutical composition | |
| ZA200701932B (en) | Pharmaceutical composition | |
| GB0425255D0 (en) | Pharmaceutical composition | |
| EP1809298A4 (en) | NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS CONTAINING SPIROSTENOL | |
| HK1065477A1 (en) | Pharmaceutical composition | |
| ZA200701931B (en) | Pharmaceutical composition | |
| GB0406014D0 (en) | Pharmaceutical composition and use |